133 related articles for article (PubMed ID: 11943900)
1. Pulmonary toxicity secondary to procarbazine.
Mahmood T; Mudad R
Am J Clin Oncol; 2002 Apr; 25(2):187-8. PubMed ID: 11943900
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary toxicity following MOPP chemotherapy.
Millward MJ; Cohney SJ; Byrne MJ; Ryan GF
Aust N Z J Med; 1990 Jun; 20(3):245-8. PubMed ID: 2196871
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy in the treatment of Hodgkin's disease.
Canellos GP; Come SE; Skarin AT
Semin Hematol; 1983 Jan; 20(1):1-24. PubMed ID: 6189191
[No Abstract] [Full Text] [Related]
4. Treatment of childhood Hodgkin's disease.
Ekert H
J Clin Oncol; 1991 Mar; 9(3):528-9. PubMed ID: 1999723
[No Abstract] [Full Text] [Related]
5. Acute pneumonitis associated with MOPP chemotherapy of Hodgkin's disease.
Cersosimo RJ; Licciardello JT; Matthews SJ; Bromer R; Hong WK
Drug Intell Clin Pharm; 1984; 18(7-8):609-11. PubMed ID: 6101251
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
Swerdlow AJ; Schoemaker MJ; Allerton R; Horwich A; Barber JA; Cunningham D; Lister TA; Rohatiner AZ; Vaughan Hudson G; Williams MV; Linch DC
J Clin Oncol; 2001 Mar; 19(6):1610-8. PubMed ID: 11250989
[TBL] [Abstract][Full Text] [Related]
7. [Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy].
Matusewicz W; Drzewoski J; Robak T; Krykowski E
Kardiol Pol; 1983; 26(7):591-4. PubMed ID: 6689036
[No Abstract] [Full Text] [Related]
8. Immunoblastic lymphoma following therapy for Hodgkin's disease. A case report.
Casini M; Pianezze G; Fabris P; Cemin S; Coser P
Haematologica; 1986; 71(1):50-2. PubMed ID: 3084357
[No Abstract] [Full Text] [Related]
9. Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone.
Farney RJ; Morris AH; Armstrong JD; Hammer S
Am Rev Respir Dis; 1977 Jan; 115(1):135-45. PubMed ID: 835882
[TBL] [Abstract][Full Text] [Related]
10. Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group Study.
Jones SE; Haut A; Weick JK; Wilson HE; Grozea P; Fabian CJ; McKelvey E; Byrne GE; Hartsock R; Dixon DO; Coltman CA
Cancer; 1983 Apr; 51(8):1339-47. PubMed ID: 6186355
[No Abstract] [Full Text] [Related]
11. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
[TBL] [Abstract][Full Text] [Related]
12. [Acute leukemia in patients treated for Hodgkin's disease].
Boccaccio P; Rosa F; Casciaro S; D'Elia P; Romagnoli M; Ghio R
Recenti Prog Med; 1988 Jan; 79(1):32-7. PubMed ID: 3375542
[No Abstract] [Full Text] [Related]
13. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
[TBL] [Abstract][Full Text] [Related]
14. Male infertility caused by the chemotherapy of Hodgkin's disease: MOPP versus ABVD.
Ragni G; Lombardi C; Santoro A; Bestetti O; Wyssling H
Acta Eur Fertil; 1983; 14(3):221-2. PubMed ID: 6199937
[No Abstract] [Full Text] [Related]
15. Long-term follow-up of survival in Hodgkin's lymphoma.
Canellos GP; Niedzwiecki D; Johnson JL
N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
[No Abstract] [Full Text] [Related]
16. Delayed life-threatening pneumonitis secondary to procarbazine.
Brooks BJ; Hendler NB; Alvarez S; Ancalmo N; Grinton SF
Am J Clin Oncol; 1990 Jun; 13(3):244-6. PubMed ID: 2346130
[TBL] [Abstract][Full Text] [Related]
17. Osteonecrosis of the femoral head following treatment for Hodgkin's disease.
Murray F; Daly PA; Freyne PJ
Ir J Med Sci; 1983 Jul; 152(7):286-8. PubMed ID: 6688611
[No Abstract] [Full Text] [Related]
18. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
19. MOPP, ABVD, or both to treat Hodgkin's disease.
Aisenberg AC
N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
[No Abstract] [Full Text] [Related]
20. Gallium citrate Ga 67 accumulation in pulmonary lesions after chemotherapy (MOPP).
Wells JD; Huskison WT; Davenport OL
South Med J; 1986 Oct; 79(10):1293-6. PubMed ID: 3464101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
